Australia · Company Research
NeuroScientific’s StemSmart result gives ASX investors a cleaner story to track
For a small biotech, clarity can be just as important as excitement. NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has spent the past year reshaping itself around StemSmart, a patented mesenchymal…
